Follicular lymphoma is an indolent malignancy with a generally favorable prognosis, with survival often measured in decades. Yet up to 20% of patients develop early progression after starting ...

A 2012 study of patients with low-tumor-burden follicular lymphoma showed that the 4-year freedom from treatment failure rate of watch-and-wait patients was not inferior to that o ...

Non-Hodgkin's lymphoma ... prognosis. However, there are more aggressive types that require intense cancer treatment. Although rare, some skin lymphomas can spread and eventually cause death. Skin ...

It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a partially follicular pattern. It is positive for the B-cell markers CD10, CD19 ...

Read on to learn more about the stages of SCC, their symptoms, treatment options, and prognosis. At stage 0, atypical cells are only present in the top layer of the skin or tissue. It has not ...

Wojciech Jurczak, MD, PhD, discusses the future of B-cell lymphoma therapy ... In lymphomas where BTK inhibition is less effective, such as follicular lymphoma, zanubrutinib combined with rituximab ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases ...

In a recent Phase II study, 46 relapsed patients with indolent or aggressive B-cell NHL (the majority with follicular lymphoma) received oblimersen combined with rituximab. [75] Responses were ...

What Is B-Cell Lymphoma? B-cell lymphoma is a cancer ... About one in five people with lymphoma have follicular lymphoma. This is a slow-growing form that mainly affects older adults.